- Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG studyIntroduction of new myeloma therapies offers new options for patients [...]
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myelomaThe updated criteria for the diagnosis of myeloma represent a [...]
- Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working GroupThe International Myeloma Working Group consensus aimed to provide recommendations [...]
- Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG studyIntroduction of new myeloma therapies offers new options for patients [...]
- Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working GroupThe International Myeloma Working Group consensus aimed to provide recommendations [...]
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myelomaThe updated criteria for the diagnosis of myeloma represent a [...]
ASCT
bone disease
bortezomib
classification
computed tomography
consensus
cytogenetics
diagnosis
DVT
genetic
guidelines
IMWG
International myeloma working group
International Staging System
ISS
lenalidomide
magnetic resonance imaging
molecular
multiple myeloma
myeloma
patients
prognosis
response criteria
stem cell
survival
thalidomide
therapy
thrombosis
transplantation
treatment
Categories
- Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy Search